Hep Grow Tablet contains L-Ornithine L-Aspartate 1000 mg, a compound widely used in the management of hepatic encephalopathy and liver dysfunction. L-Ornithine L-Aspartate acts by promoting the detoxification of ammonia, a neurotoxic substance that accumulates in patients with impaired liver function. It facilitates the conversion of ammonia into urea and glutamine, thereby reducing blood ammonia levels and improving cognitive function in affected individuals. Hep Grow is indicated as an adjunctive therapy in chronic liver diseases such as cirrhosis and acute hepatic encephalopathy to alleviate symptoms related to hyperammonemia. The tablet is typically administered orally, with dosage and duration tailored according to the severity of the condition and clinical response. Hep Grow is generally well tolerated; however, patients should be monitored for any adverse effects, and use should be cautious in individuals with hypersensitivity to any component of the formulation. It is essential to use Hep Grow under medical supervision, particularly in patients with severe hepatic impairment or concomitant illnesses. This medication supports liver function by enhancing ammonia metabolism, thereby contributing to improved neurological outcomes in hepatic encephalopathy.